Skip to content

Panic exposure app improved symptoms versus waiting; advantage over meditation remains unclear

Adults using an exposure app reported less severe panic symptoms than a waiting group. The trial found no statistically significant overall symptom differences between exposure and meditation apps.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The exposure app reduced self-reported panic and agoraphobia symptom severity compared with waiting. However, the trial did not detect an overall symptom difference between the exposure and meditation apps at either assessment. These results support benefit compared with a waiting list, while leaving any advantage over an active app unresolved.

Keep in mind

This abstract-based explanation covers a short study in which additional psychotherapy was not allowed. It cannot establish longer-term effects or whether the apps are equally effective; a nonsignificant difference does not demonstrate equivalence.

THE NUMBERS, WITH CONTEXT

What researchers found

Cohen d = 0.55

Self-reported panic and agoraphobia symptom severity

Exposure app versus waiting list at 5 weeks (P=.04). This standardized difference describes the gap relative to score variability, rather than raw symptom-scale points; lower symptom severity favored exposure.

J Med Internet Res, 2025 · Original source ↓

What exposure involved

The exposure app addressed bodily sensations and real-life situations linked to panic symptoms. Participants used it independently. The comparison app offered mindfulness meditation without being tailored to panic disorder.

Secondary outcomes

At follow-up, the exposure group also improved more than the waiting group in depressive symptoms and psychological quality of life. These secondary findings do not establish an advantage over meditation.

CHECK THE ORIGINAL

The original publication

Mobile App-Guided Exposure Therapy for Panic Disorder With and Without Agoraphobia: Randomized Controlled Trial.

Guth M, Wiebe A, Ekhlas-Schumann M et al.
J Med Internet Res · 2025

PubMed ID
41259714
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.